首页> 外文会议>Conference of the Spanish Association for Artificial Intelligence >Risk Factors for Development of Antibiotic Resistance of Enterococcus Faecium to Vancomycin. A Subgroup Discovery Approach
【24h】

Risk Factors for Development of Antibiotic Resistance of Enterococcus Faecium to Vancomycin. A Subgroup Discovery Approach

机译:肠球菌粪便抗生素抗性对万古霉素的危险因素。亚组发现方法

获取原文
获取外文期刊封面目录资料

摘要

Health-care associated infections (HAI) are infections that are not present or incubated at the time of admission to hospital. HAI are one of the major causes of morbidity and mortality among immunocompromised patients and have an important economic impact. The bacteria isolated in microbiology cultures can be treated with a limited combination of antibiotics owing to their resistance to many groups of antibiotics, which represents a major challenge. This paper focuses on the problem of vancomycin resistant Enterococcus faecium (VREfm) due to its high prevalence in HAI, multidrug resistance and ability to survive under intense selective pressure. We use the subgroup discovery technique to identify target populations with high risk clinical factors for VREfm infections that we shall be able to incorporate into a clinical decision support system for antimicrobial stewardship program. The dataset used contained 201 susceptibility tests with Enterococcus faecium from a University Hospital in years 2014 and 2015. The clinician evaluated and discussed the knowledge reported by the most interesting subgroups based on their positive predictive value and sensitivity.
机译:医疗保健相关的感染(HAI)是在入院时不存在或孵育的感染。海是免疫表明患者中发病率和死亡率的主要原因之一,并具有重要的经济影响。由于它们对许多抗生素组的抗性而言,微生物学培养中分离的细菌可以用有限的抗生素组合治疗,这是一种主要挑战。本文侧重于万古霉素抗病患者抗病患者(VREFM)由于其在激烈的选择性压力下患病的高患病率。我们使用亚组发现技术鉴定具有高风险临床因素的目标群体,用于VREFM感染,我们将能够纳入临床决策支持系统,用于抗微生物管理计划。二零一四年和二零一五年二年和2015年,使用来自大学医院的肠球菌粪便的数据集2015年。临床医生根据其积极的预测价值和敏感性评估并讨论了最有趣的亚组报告的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号